Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities - PubMed (original) (raw)
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
Joaquim Soler et al. Psychopharmacology (Berl). 2016 Mar.
Abstract
Background: Ayahuasca is a psychotropic plant tea used for ritual purposes by the indigenous populations of the Amazon. In the last two decades, its use has expanded worldwide. The tea contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT), plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties. Acute administration induces an introspective dream-like experience characterized by visions and autobiographic and emotional memories. Studies of long-term users have suggested its therapeutic potential, reporting that its use has helped individuals abandon the consumption of addictive drugs. Furthermore, recent open-label studies in patients with treatment-resistant depression found that a single ayahuasca dose induced a rapid antidepressant effect that was maintained weeks after administration. Here, we conducted an exploratory study of the psychological mechanisms that could underlie the beneficial effects of ayahuasca.
Methods: We assessed a group of 25 individuals before and 24 h after an ayahuasca session using two instruments designed to measure mindfulness capacities: The Five Facets Mindfulness Questionnaire (FFMQ) and the Experiences Questionnaire (EQ).
Results: Ayahuasca intake led to significant increases in two facets of the FFMQ indicating a reduction in judgmental processing of experiences and in inner reactivity. It also led to a significant increase in decentering ability as measured by the EQ. These changes are classic goals of conventional mindfulness training, and the scores obtained are in the range of those observed after extensive mindfulness practice.
Conclusions: The present findings support the claim that ayahuasca has therapeutic potential and suggest that this potential is due to an increase in mindfulness capacities.
Keywords: Ayahuasca; Decentering; Human; Mindfulness; Therapeutic potential.
Similar articles
- Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
Kuypers KP, Riba J, de la Fuente Revenga M, Barker S, Theunissen EL, Ramaekers JG. Kuypers KP, et al. Psychopharmacology (Berl). 2016 Sep;233(18):3395-403. doi: 10.1007/s00213-016-4377-8. Epub 2016 Jul 19. Psychopharmacology (Berl). 2016. PMID: 27435062 Free PMC article. - Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E, Soler J, Elices M, Pascual JC, Álvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J. Domínguez-Clavé E, et al. Brain Res Bull. 2016 Sep;126(Pt 1):89-101. doi: 10.1016/j.brainresbull.2016.03.002. Epub 2016 Mar 11. Brain Res Bull. 2016. PMID: 26976063 Review. - Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits.
Domínguez-Clavé E, Soler J, Pascual JC, Elices M, Franquesa A, Valle M, Alvarez E, Riba J. Domínguez-Clavé E, et al. Psychopharmacology (Berl). 2019 Feb;236(2):573-580. doi: 10.1007/s00213-018-5085-3. Epub 2018 Nov 7. Psychopharmacology (Berl). 2019. PMID: 30406413 - Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.
Soler J, Elices M, Dominguez-Clavé E, Pascual JC, Feilding A, Navarro-Gil M, García-Campayo J, Riba J. Soler J, et al. Front Pharmacol. 2018 Mar 20;9:224. doi: 10.3389/fphar.2018.00224. eCollection 2018. Front Pharmacol. 2018. PMID: 29615905 Free PMC article. - Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J, Hallak J, Dursun SM, Baker G. Hamill J, et al. Curr Neuropharmacol. 2019;17(2):108-128. doi: 10.2174/1570159X16666180125095902. Curr Neuropharmacol. 2019. PMID: 29366418 Free PMC article. Review.
Cited by
- The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.
Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. Dos Santos RG, et al. Risk Manag Healthc Policy. 2021 Mar 5;14:901-910. doi: 10.2147/RMHP.S300656. eCollection 2021. Risk Manag Healthc Policy. 2021. PMID: 33707976 Free PMC article. Review. - Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs.
Marchetta E, Mancini GF, Morena M, Campolongo P. Marchetta E, et al. Curr Neuropharmacol. 2023;21(3):687-707. doi: 10.2174/1570159X21666221207162750. Curr Neuropharmacol. 2023. PMID: 36503450 Free PMC article. Review. - Psychedelics, Meditation, and Self-Consciousness.
Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A. Millière R, et al. Front Psychol. 2018 Sep 4;9:1475. doi: 10.3389/fpsyg.2018.01475. eCollection 2018. Front Psychol. 2018. PMID: 30245648 Free PMC article. - Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
Kuypers KP, Riba J, de la Fuente Revenga M, Barker S, Theunissen EL, Ramaekers JG. Kuypers KP, et al. Psychopharmacology (Berl). 2016 Sep;233(18):3395-403. doi: 10.1007/s00213-016-4377-8. Epub 2016 Jul 19. Psychopharmacology (Berl). 2016. PMID: 27435062 Free PMC article. - Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.
Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H. Wolff M, et al. Front Psychiatry. 2020 Feb 21;11:5. doi: 10.3389/fpsyt.2020.00005. eCollection 2020. Front Psychiatry. 2020. PMID: 32153433 Free PMC article.
References
- J Pers Soc Psychol. 2003 Apr;84(4):822-48 - PubMed
- Arch Gen Psychiatry. 2006 Jul;63(7):749-55 - PubMed
- Psychopharmacology (Berl). 2001 Feb;154(1):85-95 - PubMed
- J Consult Clin Psychol. 2015 Apr;83(2):395-404 - PubMed
- PLoS One. 2014 Jan 22;9(1):e86622 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources